indianstockmarket
Home Results Stocks to Buy About Us Contact Us
 
indianstockmarket
 
ABB Limited
ACC Limited
Bajaj Auto Ltd
Bharti Airtel Limited
Bharat Heavy Electricals Ltd
Cipla Ltd
Dabur India Ltd
Dr. Reddy's Laboratories
GAIL (India) Limited
GlaxoSmithKline Ltd
Grasim Industries Ltd
Gujarat Ambuja Cement Ltd
HCL Technologies Ltd
H D F C
HDFC Bank Ltd
Hero Honda Motors Ltd
Hindalco Industries Ltd
Hindustan Lever Ltd
H P C L
ICICI Bank Ltd
Infosys Technologies Ltd
I P C L
I T C Ltd
Jet Airways (India) Ltd
Larsen & Toubro Limited
Mahindra & Mahindra Ltd
Maruti Udyog Limited
M T N L
N A L C O
Oil & Natural Gas Corpn Ltd
Oriental Bank of Commerce
Punjab National Bank
Ranbaxy Laboratories Ltd
Reliance Communications
Reliance Energy Ltd
Reliance Industries Ltd
Steel Authority of India Ltd
Satyam Computer Services
State Bank of India
Siemens Ltd
Sun Pharmaceuticals
Suzlon Energy Ltd
Tata Motors Limited
Tata Power Co. Ltd
Tata Steel Limited
Tata Consultancy Services
V S N L
Wipro Ltd
Zee Telefilms Ltd
 
http://mumbaibull.com
 
http://winfromus.com
 

Indian Stock Market

Indianstockmarket.net is an effort to educate indian investor by providing useful stock news, stock market websites, informative articles, resources to various investment guides.
Fri, 27 Jun 2008 05:05:02 GMT

Daiichi Sankyo May Sell Debt to Pay Half Ranbaxy Cost (Update1) (Bloomberg.com)
June 27 (Bloomberg) -- Daiichi Sankyo Co. , Japan's third- largest drugmaker, may sell debt to raise half the cost of its $4.6 billion acquisition of Ranbaxy Laboratories Ltd.
Fri, 04 Jul 2008 13:09:58 GMT

India stock futures end higher on fresh buying (Reuters via Yahoo! Philippines News)
MUMBAI, July 4 (Reuters) - Indian stock futures rose on Friday as investors built fresh buy positions in the index and futures of most major sectors, but analysts worried if the gains would be sustainable next week.
Wed, 25 Jun 2008 08:12:47 GMT

India's Ranbaxy gets FDA nod for Valcyte generic (Reuters via Yahoo! Singapore News)
MUMBAI, June 25 (Reuters) - India's Ranbaxy Laboratories Ltd said it had received tentative approval from the U.S. Food and Drug Administration for the generic version of Roche's anti-viral Valcyte, saying it believed it was the first to file.
Thu, 03 Jul 2008 07:57:07 GMT

AZ's Seroquel protected against generics (The News Journal)
AstraZeneca PLC won a crucial court ruling in its bid to fend off the introduction of generic versions of its second-biggest-selling drug, Seroquel.
Thu, 03 Jul 2008 10:42:07 GMT

Shrinking market sends Japan Inc buying abroad (The Economic Times)
Japanese companies are turning increasingly to overseas acquisitions, spurred by a stagnant domestic economy
Wed, 25 Jun 2008 11:07:38 GMT

Ranbaxy receives USFDA approval (Business Standard India)
Ranbaxy Laboratories Ltd has received tentative approval from the US Food and Drug Administration to manufacture and market the generic version of Roche's Valcyte (Valganciclovir Hydrochloride Tablets, 450 mg), a medicine used by AIDS patients.
Fri, 27 Jun 2008 23:47:09 GMT

Daiichi may sell debt to raise funds (The Star)
TOKYO: Daiichi Sankyo Co, Japan’s third largest drugmaker, may sell debt to raise half the cost of its US$4.6bil acquisition of Ranbaxy Laboratories Ltd, the biggest Indian pharmaceuticals firm.
 
Wed, 11 Jun 2008 17:27:43 GMT


Citizen

Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic ...
FOXBusiness - Jun 11, 2008
JP) ("Daiichi Sankyo"), one of the largest pharmaceutical companies in Japan, and Ranbaxy Laboratories Limited (NSE/BSE: Ranbaxy/500359) ("Ranbaxy"), ...
Ranbaxy Laboratories Rises on Report Owners May Sell Stake Bloomberg
Ranbaxy drug buy a sign India predators may now be prey Reuters
Report on Pfizer move buoys Ranbaxy stock to a 3-year high domain-B
Wall Street Journal - Economic Times
all 755 news articles
Fri, 04 Jul 2008 07:38:51 GMT


Business Standard

Pfizer likely to top Daiichi offer for Ranbaxy by 20%, report says
MarketWatch - Jul 4, 2008
TO) to buy a majority stake in Indian drugmaker Ranbaxy Laboratories Ltd. (500359.BY: , , ) , Financial Chronicle reported Friday, without citing any ...
CARE assigns 'PR1+' to bank loan facilities of Ranbaxy Economic Times
`There is no emerging trend in Ranbaxy`s move` Business Standard
Patent-obsessed big pharma joining hands with generics competitors Economic Times
Economic Times - Economic Times
all 8 news articles
Wed, 18 Jun 2008 18:45:02 GMT


Times Now.tv

Ranbaxy settles worldwide patent litigations with Pfizer
Hindu Business Line, India - Jun 18, 2008
New Delhi, June 18 Ranbaxy Laboratories Ltd and Pfizer Inc have agreed to settle most of their patent litigations worldwide involving the blockbuster ...
Pfizer settles Lipitor patent litigation with Ranbaxy Laboratories Forbes
Pfizer Rises After Ranbaxy Delays Generic Lipitor (Update1) Bloomberg
Ranbaxy settles with Pfizer over generic Lipitor Bizjournals.com
CNNMoney.com - Earthtimes (press release)
all 316 news articles
Wed, 11 Jun 2008 12:04:23 GMT


Indian shares rebound 2 pct, Ranbaxy ends flat
Reuters India, India - Jun 11, 2008
Ranbaxy Laboratories Ltd (RANB.BO: Quote, Profile, Research), India's leading drug maker by sales, raced to a 3-1/2-year high after Daiichi Sankyo (4568. ...
Indian shares open 0.5 pct higher Reuters India
India Hot Stocks:Select pharma stocks up on institutional buying Reuters India
all 72 news articles
Fri, 04 Jul 2008 11:24:06 GMT


India Stocks Rise; Bharat Heavy, Larsen & Toubro Advance
Bloomberg - Jul 4, 2008
Ranbaxy Laboratories Ltd. (RBXY IN) rose 24.45 rupees, or 4.8 percent, to 538.40, the most since June 10. Pfizer Inc., the world's biggest drugmaker, ...
Thu, 19 Jun 2008 05:24:20 GMT


Gulf Times

India Stocks: Ranbaxy Laboratories, Union Bank Decline
Bloomberg - Jun 18, 2008
Ranbaxy Laboratories Ltd. (RBXY IN) fell 35.50 rupees, or 5.9 percent, to 562. India's biggest drugmaker and Pfizer Inc. agreed to keep generic versions of ...
Indian shares end lower on renewed worries about the global ... Forbes
Indian shares lower; Ranbaxy slips on patent settlement with Pfizer Forbes
Indian shares rise slightly after flat open; domestic concerns ... Forbes
Forbes - Forbes
all 100 news articles
Wed, 18 Jun 2008 07:19:17 GMT


Indian shares open little changed; cement shares, Ranbaxy in focus
Forbes, NY - Jun 18, 2008
Ranbaxy Laboratories Ltd. gained 2.24 percent to trade at 594.50 rupees on a media report suggesting that the company's majority shareholders may sell their ...
India's Stocks Post Biggest Decline in a Week, Led by ICICI Bloomberg
all 5 news articles
 
Directory | Disclaimer
 
Developed by WorldITLab.
 
Copyright © 2004 - 2007 indianstockmarket.net . All rights reserved worldwide.
 
Content by Stock Market Guide